Conference
FOSTAMATINIB, A SPLEEN TYROSINE KINASE INHIBITOR, IS ACTIVE IN THE TREATMENT OF WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA: RESULTS OF THE SOAR PHASE 2, MULTICENTER, OPEN-LABEL STUDY
Authors
Kuter DJ; Arnold D; Agajanian R; Choi M; Lichtin A; Rogers KA; Boxer MA; Broome C; Field JJ; Murakhovskaya I
Volume
93
Pagination
pp. E34-E35
Publisher
WILEY
Publication Date
September 1, 2018
Conference proceedings
AMERICAN JOURNAL OF HEMATOLOGY
Issue
9
ISSN
0361-8609